Medizinische Klinik

, 94:251

Update Angiologie



  1. 1.
    Abizaid A, Satler LF, Monsein L, et al. IVUS guidance improves acute results in patients undergoing stent deployment to treat carotid artery disease. Circulation 1998; 98: 1–137.Google Scholar
  2. 2.
    AbuRahma AF, Robinson PA, Strickler DL, et al. Proposed new duplex classification for threshold stenoses used in various symptomatic and asymptomatic carotid endarterectomy trials. Ann Vasc Surg 1998; 12: 349–58.PubMedCrossRefGoogle Scholar
  3. 3.
    Agen C, Danesi R, Blandizzi C, et al. Macrolide antibiotics as antiinflammatory agents: roxithromycin in an unexspected role. Agents Actions 1993; 38: 85–90.PubMedCrossRefGoogle Scholar
  4. 4.
    Alexandrov AV, Vital D, Brodie DS, et al. Grading carotid stenosis with ultrasound. An interlaboratory comparison. Stroke 1997; 28: 1208–10.PubMedGoogle Scholar
  5. 5.
    Angelin B. Therapy for lowering lipoprotein(a) levels. Curr Opin Lipidol 1997; 8: 337–41.PubMedCrossRefGoogle Scholar
  6. 6.
    Antiplatelet Trialists’ Collaboration: Collaborative overview of randomised trials of antiplatelet therapy I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994; 308: 81–106.Google Scholar
  7. 7.
    Azen SP, Quian D, Mack WJ, et al. Effect of supplementary antioxidant vitamin intake on carotid wall intima-media-thickness in a controlled trial of cholesterol lowering. Circulation 1996; 94: 2369–72.PubMedGoogle Scholar
  8. 8.
    Babikian VL, Wijman CA, Hyde C, et al. Cerebral microembolism and early recurrent cerebral or retinal ischemic events. Stroke 1997; 28: 1314–8.PubMedGoogle Scholar
  9. 9.
    Baldt MM, Zontsich T, Stümpflen A, et al. Deep venous thrombosis of the lower extremity: efficacy of spiral CT venography compared with conventional venography in diagnosis. Radiology 1996; 200: 423–8.PubMedGoogle Scholar
  10. 10.
    Barnett HJM, Taylor DW, Eliasziw M, et al., for the North American Symptomatic Carotid Endarterectomy Trial Collaborators: Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med 1998; 339: 1415–25.PubMedCrossRefGoogle Scholar
  11. 11.
    Becker DM, Philbrick JT, Bachhuber TL, et al. D-dimer testing and acute venous thromboembolism. Arch Intern Med 1996; 156: 939–46.PubMedCrossRefGoogle Scholar
  12. 12.
    Berenson GS, Srinivasan SR, Bao W, et al., for the Bogalusa Heart Study. N Engl J Med 1998; 338: 1650–6.PubMedCrossRefGoogle Scholar
  13. 13.
    Berman SS, Devine JJ, Erdoes LS, et al. Distinguishing carotid artery pseudo-occlusion with color-flow Doppler. Stroke 1995; 26: 434–8.PubMedGoogle Scholar
  14. 14.
    Bernardi E, Prandoni P, Lensing AWA, et al., on behalf of the Multicentre Italian D-dimer Ultrasound Study Investigators Group. Br Med J 1998; 317: 1037–40.Google Scholar
  15. 15.
    Biller J, Feinberg WM, Castaldo JE, et al. Guidelines for carotid endarterectomy. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Circulation 1998; 97: 501–9.PubMedGoogle Scholar
  16. 16.
    Bots ML, Hoes AW, Koudstaal PJ, et al. Common-carotid intima-media thickness and risk of stroke and myocardial infarction. The Rotterdam Study. Circulation 1997; 96: 1432–7.PubMedGoogle Scholar
  17. 17.
    Brandl R, Richter T, Haug K, et al. Topographic analysis of proliferative activity in carotid endarterectomy specimens by immunocytochemical detection of the cell cyclenrelated antigen Ki-67. Stroke 1997; 96: 3360–8.Google Scholar
  18. 18.
    Bucher HC, Griffith LE, Guyatt GH. Effect of HMG CoA reductase inhibitors on stroke: a meta-analysis of randomised, controlled trials. Ann Intern Med 1998; 128: 89–95.PubMedGoogle Scholar
  19. 19.
    Camargo CA Jr, Stampfer MJ, Glynn RJ, et al. Prospective study of moderate alcohol consumption and risk of peripheral arterial disease in US male physicians. Circulation 1997; 95: 577–80.PubMedGoogle Scholar
  20. 20.
    CAPRIE Steering Committee. A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329–39.CrossRefGoogle Scholar
  21. 21.
    Carpenter JP, Lexa FJ, Davis JT. Determination of duplex Doppler ultrasound criteria appropriate to the North American Symptomatic Carotid Endarterectomy Trial. Stroke 1996; 27: 695–9.PubMedGoogle Scholar
  22. 22.
    Casscells W, Hathorn B, David M, et al. Thermal detection of cellular infiltrates in living atherosclerotic plaques: possible implications for plaque rupture and thrombosis. Lancet 1996; 347: 1447–9.PubMedCrossRefGoogle Scholar
  23. 23.
    Celermajer DS, Adams MR, Clarkson P, et al. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med 1996; 334: 150–4.PubMedCrossRefGoogle Scholar
  24. 24.
    Chassin MR. Appropriate use of carotid endarterectomy. N Engl J Med 1998; 339: 1468–71.PubMedCrossRefGoogle Scholar
  25. 25.
    Chengelis DL, Bendick PJ, Glover PJL, et al. Progression of superficial venous thrombosis to deep vein thrombosis. J Vasc Surg 1996; 24: 745–9.PubMedCrossRefGoogle Scholar
  26. 26.
    Cinat M, Lane CT, Pham H, et al. Helical CT angiography in the preoperative evaluation of carotid artery stenosis. J Vasc Surg 1998; 28: 290–300.PubMedCrossRefGoogle Scholar
  27. 27.
    Cockcroft JR, Chowienczyk PJ, Benjamin N, et al. Preserved endothelium-dependent vasodilatation in patients with essential hypertension. N Engl J Med 1994; 330: 1036–40.PubMedCrossRefGoogle Scholar
  28. 28.
    Cook PJ, Honeybourne D, Lip GY, et al. Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: the West Birmingham Stroke Project. Stroke 1998; 29: 404–10.PubMedGoogle Scholar
  29. 29.
    Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004–8.PubMedCrossRefGoogle Scholar
  30. 30.
    Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997; 350: 430–6.PubMedCrossRefGoogle Scholar
  31. 31.
    Danesh J, Peto R. Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. Br Med J 1998; 316: 1130–2.Google Scholar
  32. 32.
    Davis SF, Yeung AC, Meredith IT, et al. Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year posttransplant. Circulation 1996; 93: 457–62.PubMedGoogle Scholar
  33. 33.
    De Moerloose P, Bounameaux HR, Mannucci PM. Screening test for thrombophilic patients: which tests, for which patient, by whom, when, and why? Semin Thromb Hemostas 1998; 24: 321–7.CrossRefGoogle Scholar
  34. 34.
    Den Heijer M, Koster T, Blom HJ, et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996; 334: 759–62.CrossRefGoogle Scholar
  35. 35.
    Derdeyn CP, Powers WJ, Moran CJ, et al. Role of Doppler US in screening for carotid atherosclerotic disease. Radiology 1995; 197: 635–43.PubMedGoogle Scholar
  36. 36.
    De Stefano V, Chiusolo P, Paciaroni K, et al. Epidemiology of factor V Leiden: clinical implications. Semin Thromb Hemostas 1998; 24: 367–79.CrossRefGoogle Scholar
  37. 37.
    Diehm C, Stammler F, Amendt K. Die tiefe Venenthrombose. Diagnostik und Therapie. Dtsch Ärztebl 1997; 94: A301–11.Google Scholar
  38. 38.
    Diener HC. Primär- und Sekundärprävention des ischämischen Insultes. Dtsch Ärztebl 1997; 94: A2195–201.Google Scholar
  39. 39.
    Diethrich EB, Ndiaye M, Reid DB. Stenting in the carotid artery: initial experience in 110 patients. J Endovasc Surg 1996; 3: 42–62.PubMedCrossRefGoogle Scholar
  40. 40.
    Donnan GA, Davis SM, Chambers BR, et al. Surgery for prevention of stroke. Lancet 1998; 351: 1372–3.PubMedCrossRefGoogle Scholar
  41. 41.
    Droste DW, Decker W, Siemens HJ, et al. Variability in occurence of embolic signals in long term transcranial Doppler recordings. Neurol Res 1996; 18: 25–30.PubMedGoogle Scholar
  42. 42.
    Dumenco LL, Blair AJ, Sweeney JD. The results of diagnostic st dies for thrombophilia in a large group of patients with a personal or family history of thrombosis. Am J Clin Pathol 1998; 110: 673–82.PubMedGoogle Scholar
  43. 43.
    Dupas B, el Kouri D, Curtet C, et al. Angiomagnetic resonance imaging of iliofemorocaval venous thrombosis. Lancet 1995; 346: 17–9.PubMedCrossRefGoogle Scholar
  44. 44.
    Eichlisberger R, Widmer MT, Frauchiger B, et al. Zur Häufigkeit des postthrombotischen Syndroms. Wien Med Wochenschr 1994; 144: 192–5.PubMedGoogle Scholar
  45. 45.
    Eliasziw M, Smith RF, Singh N, et al. Further comments on the measurement of carotid stenosis from angiograms. Stroke 1994; 25: 2445–9.PubMedGoogle Scholar
  46. 46.
    Enderle MD, Balletshofer BM, Schmülling RM, et al. Atherosklerose-Früherkennung mit hochauflösendem Ultraschall am Beispiel von Typ II-Diabetikern. Ultraschall Med 1998; 19: 16–21.PubMedCrossRefGoogle Scholar
  47. 47.
    Ernst E, Resch K. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 1993; 118: 956–63.PubMedGoogle Scholar
  48. 48.
    Espeland MA, Craven TE, Riley WA, et al., for the Asymptomatic Carotid Artery Progression Study Research Group: Reliability of longitudinal ultrasonographic measurements of carotid intimal-medial thickness. Stroke 1996; 27: 480–5.PubMedGoogle Scholar
  49. 49.
    European Carotid Surgery Trialists’ Collaborative Group: Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998; 351: 1379–87.CrossRefGoogle Scholar
  50. 50.
    Executive Committee for the Asymptomatic Carotid Atherosclerosis Study: Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995; 273: 1421–8.CrossRefGoogle Scholar
  51. 51.
    Fabricant CG, Fabricant J, Litrenta MM, et al. Virus-induced atherosclerosis. J Exp Med 1978; 148: 335–40.PubMedCrossRefGoogle Scholar
  52. 52.
    Fermo I, Vigano DíAngelo S, Paroni R, et al. Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease. Ann Intern Med 1995; 123: 747–53.PubMedGoogle Scholar
  53. 53.
    Folsom AR, Eckfeldt JH, Weitzman S, et al., for the Atherosclerosis Risc in Communities (ARIC) Study Investigators: Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity. Stroke 1994; 25: 66–73.PubMedGoogle Scholar
  54. 54.
    Folsom AR, Nieto J, McGovern PG, et al. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins. The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 1998; 98: 204–10.PubMedGoogle Scholar
  55. 55.
    Folsom AR, Nieto FJ, Sorlie P, et al. Helicobacter pylori seropositivity and coronary heart disease incidence. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation 1998; 98: 845–50.PubMedGoogle Scholar
  56. 56.
    Forbes K, Stevenson AJ. The use of power Doppler ultrasound in the diagnosis of isolated deep venous thrombosis of the calf. Clin Radiol 1998; 53: 752–4.PubMedCrossRefGoogle Scholar
  57. 57.
    Franzeck UK, Schalch I, Jäger KA, et al. Prospective 12-year follow-up study of clinical and hemodynamic sequelae after deep vein thrombosis in low-risk patients (Zürich Study). Circulation 1996; 93: 74–9.PubMedGoogle Scholar
  58. 58.
    Fürst G, Sitzer M, Hofer M, et al. Kontrastmittelverstärkte farbcodierte Duplexsonographie hochgradiger Karotisstenosen. Ultraschall Med 1995; 16: 140–4.PubMedCrossRefGoogle Scholar
  59. 59.
    Ganzer D, Gutezeit A, Mayer G, et al. Thromboembolieprophylaxe als Auslöser thromboembolischer Komplikationen. Eine Untersuchung zur Inzidenz der heparin-induzierten Thrombopenie (HIT) Typ II. Z Orthop Grenzgeb 1997; 135: 543–9.CrossRefGoogle Scholar
  60. 60.
    Georgiadis D, Hill M, Kottkamp H, et al. Intracranial microembolic signals during radiofrequency ablation of accessory pathways. Am J Cardiol 1997; 80: 805–7.PubMedCrossRefGoogle Scholar
  61. 61.
    Gerraty RP, Bowser DN, Infeld B, et al. Microemboli during carotid angiography. Association with stroke risk factors or subsequent magnetic resonance imaging changes? Stroke 1996; 27: 1543–7.PubMedGoogle Scholar
  62. 62.
    Gillum RF, Ingram DD, Makuc DM. White blood cell count and stroke: the NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 1994; 139: 894–902.PubMedGoogle Scholar
  63. 63.
    Ginsberg JS, Wells PS, Brill-Edwards P, et al. Antiphospholipid antibodies and venous thromboembolism. Blood 1995; 86: 3685–91.PubMedGoogle Scholar
  64. 64.
    Gnasso A, Carallo C, Irace C, et al. Association between intima-media-thickness and wall shear stress in common carotid arteries in healthy male subjects. Circulation 1996; 94: 3257–62.PubMedGoogle Scholar
  65. 65.
    Goldberg RJ, Burchfiel CM, Ried DM, et al. A prospective study of the health effects of alcohol consumption in middle-aged and elderly men. Circulation 1994; 89: 651–9.PubMedGoogle Scholar
  66. 66.
    Goldhaber SZ. Pulmonary embolism. N Engl J Med 1998; 339: 93–104.PubMedCrossRefGoogle Scholar
  67. 67.
    Grayston JT. Antibiotic treatment of Chlamydia pneumoniae for secondary prevention of cardiovascular events. Circulation 1998; 97: 1669–70.PubMedGoogle Scholar
  68. 68.
    Griewing B, Morgenstern C, Driesner F, et al. Cerebrovascular disease assessed by color flow and power Doppler ultrasonography. Comparison with digital subtraction angiography in internal carotid artery stenosis. Stroke 1996; 27: 95–100.PubMedGoogle Scholar
  69. 69.
    Groce JB IIIrd. Patient outcomes and cost analysis associated with an outpatient deep venous thrombosis treatment program. Pharmacotherapy 1998; 18: 175S-80S.PubMedGoogle Scholar
  70. 70.
    Gronbaek M, Deis A, Sorensen TIA, et al. Mortality associated with moderate intakes of wine, beer, or spirits. Br Med J 1995; 310: 1165–69.Google Scholar
  71. 71.
    Gupta S, Leatham EW, Carrington D, et al. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 1997; 96: 404–7.PubMedGoogle Scholar
  72. 72.
    Gurfinkel E, Bozovich G, Daroca A, et al., for the RO-XIS Study Group: Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. Lancet 1997; 350: 404–7.PubMedCrossRefGoogle Scholar
  73. 73.
    Harrison L, McGinnis J, Crowther JM, et al. Assessment of outpatient treatment of deep-vein thrombosis with low-molecular-weight heparin. Arch Intern Med 1998; 158: 2001–3.PubMedCrossRefGoogle Scholar
  74. 74.
    Hashimoto M, Kim S, Eto M, et al. Acute intake of red wine improves flow-mediated vasodilatation of the brachial artery in men. Circulation 1998; 98: 1–244.Google Scholar
  75. 75.
    Haynes WG, Webb DJ. Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet 1994; 344: 852–4.PubMedCrossRefGoogle Scholar
  76. 76.
    Heidrich H, Kahl K, Penninger C, et al. Heparin-induzierte Thrombozytopenien unter nichtfraktioniertem Heparin. Med Klin 1998; 93: 343–6.CrossRefGoogle Scholar
  77. 77.
    Heinz M, Theiss W. Lysetherapie venöser Thrombosen. Internist (Berlin) 1996; 37: 567–73.Google Scholar
  78. 78.
    Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996; 334: 1145–9.PubMedCrossRefGoogle Scholar
  79. 79.
    Hirsh J, Hoak J. Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals from the Council on Thrombosis (in consultation with the Council on Cardiovascular Radiology), American Heart Association. Circulation 1996; 93: 2212–45.PubMedGoogle Scholar
  80. 80.
    Hodis HN, Mack WJ, Dunn M, et al. Intermediate-density lipoproteins and progression of carotid arterial wall intima-media-thickness. Circulation 1997; 95: 2022–6.PubMedGoogle Scholar
  81. 81.
    Homocysteine Lowering Trialists’ Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Br Med J 1998; 316: 894–8.Google Scholar
  82. 82.
    Hougaku H, Matsumoto M, Handa N, et al. Asymptomatic carotid lesions and silent cerebral infarction. Stroke 1994; 25: 566–70.PubMedGoogle Scholar
  83. 83.
    Husain S, Andrews NP, Multahy D, et al. Aspirin improves endothelial dysfunction in atherosclerosis. Circulation 1998;97:716–20.PubMedGoogle Scholar
  84. 84.
    Huston J, Nichols DA, Luetmer PH, et al. MR angiographic and sonographic indications for endarterectomy. Am J Neuroradiol 1998;19:309–15.PubMedGoogle Scholar
  85. 85.
    Hwang S-J, Ballantyne CM, Sharrett AR, et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases. The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 1997;96:4219–25.PubMedGoogle Scholar
  86. 86.
    Jackson MR, Chang AS, Robles HA, et al. Determination of 60% or greater carotid stenosis: a prospective comparison of magnetic resonance angiography and duplex ultrasound with conventional angiography. Ann Vasc Surg 1998;12:236–43.PubMedCrossRefGoogle Scholar
  87. 87.
    Jander S, Sitzer M, Schumann R, et al. Inflammation in high-grade carotid stenosis: a possible role for macrophages and T cells in plaque destabilization. Stroke 1998;29:1625–30.PubMedGoogle Scholar
  88. 88.
    Jerjes-Sanchez C, Ramlrez-Rivera A, Garcia ML, et al. Streptokinase and heparin versus heparin alone in massive pulmonary embolism: a randomized controlled trial. J Thromb Thrombolys 1995;2:227–9.Google Scholar
  89. 89.
    Kadota JL. Non antibiotic effects of antibiotics. J Clin Microb Infect 1996;1(II):220–2.Google Scholar
  90. 90.
    Kaps M, Seidel G, Berg J. Is there a hemispheric side preference of cardiac valvular emboli? Ultrasound Med Biol 1995;21:753–6.PubMedCrossRefGoogle Scholar
  91. 91.
    Kearon C, Julian JA, Newman TE, et al. Noninvasive diagnosis of deep venous thrombosis. McMaster Diagnostic Imaging Practice Guidelines Initiative. Ann Intern Med 1998;128:663–77.PubMedGoogle Scholar
  92. 92.
    Kearon C, Ginsberg JS, Hirsh J. The role of venous ultrasonography in the diagnosis of suspected deep venous thrombosis and pulmonary embolism. Ann Intern Med 1998;129:1044–9.PubMedGoogle Scholar
  93. 93.
    Kiechl S, Willeit J, Egger G, et al. Alcohol consumption and carotid atherosclerosis: evidence of dose-dependent atherogenic and antiatherogenic effects. Results from the Bruneck study. Stroke 1994;25:1593–8.PubMedGoogle Scholar
  94. 94.
    Kiechl S, Willeit J, Egger G, et al., for the Bruneck Study Group: Body iron stores and the risk of carotid atherosclerosis. Prospective results from the Bruneck Study. Circulation 1997;96:3300–7.PubMedGoogle Scholar
  95. 95.
    Knecht MF, Heinrich F. Clinical ealuation of an immunoturbidimetric D-dimer assay in the diagnostic procedure of deep vein thrombosis and pulmonary embolism. Thromb Res 1997;88:413–7.PubMedCrossRefGoogle Scholar
  96. 96.
    Konstantinides S, Geibel A, Olschewski M, et al. Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism. Results of a multicenter registry. Circulation 1997;96:882–8.PubMedGoogle Scholar
  97. 97.
    Koopman MMW, Prandoni P, Piovella F, et al., for the TASMAN Study Group. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med 1996;334:682–7.PubMedCrossRefGoogle Scholar
  98. 98.
    Kuller LH, Evans RW. Homocystein, Vitamins, and Cardiovascular disease. Circulation 1998;98:196–9.PubMedGoogle Scholar
  99. 99.
    Kuntz KM, Skillman JJ, Whittemore AD, et al. Carotid endarterectomy in asymptomatic patients — is contrast angiography necessary? A morbidity analysis. J Vasc Surg 1995;22:706–14.PubMedCrossRefGoogle Scholar
  100. 100.
    Kupferminc MJ, Eldor A, Steinman N, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999; 340:9–13.PubMedCrossRefGoogle Scholar
  101. 101.
    Lee AJ, Mowbray PI, Lowe GDO, et al. Blood viscosity and elevated carotid intima-media thickness in men and women. The Edinburgh Artery Study. Circulation 1998;97:1467–73.PubMedGoogle Scholar
  102. 102.
    Lensing AWA, Prins MH, Davidson BL, et al. Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis. Arch Intern Med 1995;155:601–7.PubMedCrossRefGoogle Scholar
  103. 103.
    Levine M, Gent M, Hirsh J, et al. A comparison of lowmolecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 1996;334:677–81.PubMedCrossRefGoogle Scholar
  104. 104.
    Libby P, Egan D, Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis. An assessment of the evidence and need for future research. Circulation 1997;96:4095–103.PubMedGoogle Scholar
  105. 105.
    Ludlam CA, Bennett B, Fox KAA, et al. Guidelines for the use of thrombolytic therapy. Blood Coagulation Fibrinolysis 1995;6:273–85.PubMedCrossRefGoogle Scholar
  106. 106.
    Lynch J, Kaplan GA, Salonen R, et al. Socioeconomic status and carotid atherosclerosis. Circulation 1995;92:1786–92.PubMedGoogle Scholar
  107. 107.
    Maass M, Bartels C, Kruger S, et al. Endovascular presence of Chlamydia pneumoniae DNA is a generalized phenomenon in atherosclerotic vascular disease. Atherosclerosis 1998;140:Suppl 1:S25–30.CrossRefGoogle Scholar
  108. 108.
    MacMahon S, Sharpe N, Gamble G, et al., on behalf of the LIPID Trial Research Group. Effects of lowering average or below-average cholesterol levels on the progression of carotid atherosclerosis. Results of the LIPID atherosclerosis substudy. Circulation 1998;97:1784–90.PubMedGoogle Scholar
  109. 109.
    Mathur A, Roubin GS, Iyer SS, et al. Predictors of stroke complicating carotid artery stenting. Circulation 1998;97:1239–45.PubMedGoogle Scholar
  110. 110.
    Mattiasson I, Berntorp E, Bornhov S, et al. Out-patient treatment of acute deep vein thrombosis. Int Angiol 1998;17:146–50.PubMedGoogle Scholar
  111. 111.
    McCully KS. Vascular pathology of homocysteinemia. Am J Pathol 1969;56:111–28.PubMedGoogle Scholar
  112. 112.
    Megnien JL, Gariepy J, Saudubray JM, et al. Evidence of carotid artery wall hypertrophy in homozygous homocystinuria. Circulation 1998;98:2276–81.PubMedGoogle Scholar
  113. 113.
    Mendez MV, Scott T, LaMorte W, et al. Chronic inflammatory diseases are associated with peripheral vascular disease. Circulation 1998;98:1–207.Google Scholar
  114. 114.
    Mildenberger P, Kauczor HU, Ehrhard K, et al. CT-Angiographie bei Carotisstenosen. Radiologe 1997;37:883–90.PubMedCrossRefGoogle Scholar
  115. 115.
    Moneta GL, Edwards JM, Chitwood RW, et al. Correlation of North American Symptomatic Carotid Endarterectomy Trial (NASCET) angiographic definition of 70% to 99% internal carotid artery stenosis with duplex scanning. J Vasc Surg 1993;17:152–9.PubMedCrossRefGoogle Scholar
  116. 116.
    Monreal M, Lafoz E, Olive A, et al. Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin. Thromb Haemost 1994;71:7–11.PubMedGoogle Scholar
  117. 117.
    Moore WS, Barnett HJM, Beebe HG, et al. Guidelines for carotid endarterectomy: a multidisciplinary consensus statement from the Ad Hoc Committee, American Heart Association. Stroke 1995;26:188–201.PubMedGoogle Scholar
  118. 118.
    Moustapha A, Naso A, Nahlawi M, et al. Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. Circulation 1998;97:138–41.PubMedGoogle Scholar
  119. 119.
    Muhlestein JB, Anderson JL, Hammond EH, et al. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 1998;97:633–6.PubMedGoogle Scholar
  120. 120.
    Munro JM, Cotran RS. The pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab Invest 1988;58:249–61.PubMedGoogle Scholar
  121. 121.
    Nguyen TT, Ellefson RD, Hodge DO, et al. Predictive value of electrophoretically detected lipoprotein(a) for coronary heart disease and cerebrovascular disease in a community-based cohort of9936 men and women. Circulation 1997;96:1390–7.PubMedGoogle Scholar
  122. 122.
    North American Symptomatic Carotid Endarterectomy Trial Collaborators: Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325:445–53.Google Scholar
  123. 123.
    Nygard O, Vollset SE, Refsum H, et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 1995;274:1526–33.PubMedCrossRefGoogle Scholar
  124. 124.
    Nygard O, Nordrehaug JE, Refsum H, et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997;337:230–6.PubMedCrossRefGoogle Scholar
  125. 125.
    Oeltermann A, Riedel M, Schneider M, et al. Akute Östradiol-induzierte Gefäßeffekte beim Menschen. Vasa 1993;Suppl 41:70.Google Scholar
  126. 126.
    O’Leary DH, Polak JF, Kronmal RA, et al., for the Cardiovascular Health Study Collaborative Research Group: Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999;340:14–22.PubMedCrossRefGoogle Scholar
  127. 127.
    Omenn GS, Beresford SAA, Motulsky AG. Preventing coronary heart disease. B vitamins and homocysteine. Circulation 1998;97:421–4.PubMedGoogle Scholar
  128. 128.
    Paassilta M, Kervinen K, Rantala AO, et al. Social alcohol consumption and low Lp(a) lipoprotein concentrations in middle aged finnish men: population based study. Br Med J 1998;316:594–5.Google Scholar
  129. 129.
    Padayachee TS, Cox TC, Modaresi KB, et al. The measurement of internal carotid artery stenosis: comparison of duplex with digital subtraction angiography. Eur J Vasc Endovasc Surg 1997;13:180–5.PubMedCrossRefGoogle Scholar
  130. 130.
    Palombo C, Kozakova M, Morizzo C, et al. Real-time three-dimensional ultrasound for assessment of carotid artery stenosis: validation against angiography. Circulation 1998;98:1–101.Google Scholar
  131. 131.
    Partsch H. Diagnose und Therapie der tiefen Venenthrombose. Vasa 1996:Suppl 46.Google Scholar
  132. 132.
    Partsch H, Kechavarz B, Kohn H, et al. The effect of mobilisation of patients during treatment of thromboembolic disorders with low-molecular-weight heparin. Int Angiol 1997;16:189–92.PubMedGoogle Scholar
  133. 133.
    Partsch H, Oburger K, Mostbeck A, et al. Frequency of pulmonary embolism in ambulant patients with pelvic vein thrombosis: a prospective study. J Vasc Surg 1992;16:715–22.PubMedCrossRefGoogle Scholar
  134. 134.
    Pasceri V, Cammarota G, Patti G, et al. Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation 1998;97:1675–9.PubMedGoogle Scholar
  135. 135.
    Patel MR, Kuntz KM, Klufas RA, et al. Preoperative assessment of the carotid bifurcation. Can magnetic resonance angiography and duplex ultrasonography replace contrast arteriography? Stroke 1995;26:1753–8.PubMedGoogle Scholar
  136. 136.
    Pedersen TR, Kjekshus J, Pyorala K, et al. Effect of simvastatin on ischemic signs and symptoms in the Scandinavian Simvastatin Survival Study (4S). Am J Cardiol 1998;81:333–5.PubMedCrossRefGoogle Scholar
  137. 137.
    Perry IJ, Refsum H, Morris RW, et al. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995;346: 1395–8.PubMedCrossRefGoogle Scholar
  138. 138.
    Peterson JC, Spence D. Vitamins and progression of atherosclerosis in hyper-homocyst(e)inaemia. Lancet 1998;351:263.PubMedCrossRefGoogle Scholar
  139. 139.
    Piette J-C, Cacoub P. Antiphospholipidsyndrome in the elderly: caution (Editorial). Circulation 1998;97:2195–6.PubMedGoogle Scholar
  140. 140.
    Pignoli P, Tremoli E, Poli A, et al. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986;74:1399–406.PubMedGoogle Scholar
  141. 141.
    Prasad A, Narayanan S, Mincemoyer R, et al. Acute and long-term effects of angiotensin type I receptor inhibition on endothelial dysfunction in atherosclerosis. Circulation 1998;98:1–607.Google Scholar
  142. 142.
    Ranke C, Creutzig A. Update Angiologie. Med Klin 1995;90:467–79.Google Scholar
  143. 143.
    Ranke C, Creutzig A, Becker H, et al. Standardization of carotid ultrasound: a hemodynamic method to normalize for interindividual and interequipment variability. Stroke 1999;30:402–6.PubMedGoogle Scholar
  144. 144.
    Ranke C, Hecker H, Creutzig A, et al. Dose-dependent effect of aspirin on carotid atherosclerosis. Circulation 1993;87:1873–9.PubMedGoogle Scholar
  145. 145.
    Ranke C, Hendrickx P, Roth U, et al. Color and conventional image-directed Doppler ultrasonography: accuracy and sources of error in quantitative blood flow measurements. J Clin Ultrasound 1992;20:187–93.PubMedCrossRefGoogle Scholar
  146. 146.
    Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973–9.PubMedCrossRefGoogle Scholar
  147. 147.
    Ridker PM, Cushman M, Stampfer MJ, et al. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998; 97:425–8.PubMedGoogle Scholar
  148. 148.
    Ridker PM, Hennekens CH, Lindpaintner K, et al. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995;332:912–7.PubMedCrossRefGoogle Scholar
  149. 149.
    Ridker PM, Hennekens CH, Selhub J, et al. Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism. Circulation 1997;95:1777–82.PubMedGoogle Scholar
  150. 150.
    Ridker PM, Hennekens CH, Stampfer MJ, et al. Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke. Circulation 1998;98:2796–9.PubMedGoogle Scholar
  151. 151.
    Ries S, Schminke U, Daffertshofer M, et al. High intensity transient signals (HITS) in patients with carotid artery disease. Eur J Med Res 1996;18:328–30.Google Scholar
  152. 152.
    Ries F, Tiemann K, Pohl C, et al. High-resolution emboli detection and differentiation by characteristic postembolic spectral patterns. Stroke 1998;29:668–72.PubMedGoogle Scholar
  153. 153.
    Robinson K, Arheart K, Refsum H, et al., for the European COMAC Group. Low circulating folate and vitamin B6 concentrations. Risk factors for stroke, peripheral vascular disease, and coronary artery disease. Circulation 1997;97:437–43.Google Scholar
  154. 154.
    Roos V, Laschewski F, Böck U, et al. Plantarvenen-thrombose — Diagnostik und Therapie. Vasa 1998:Suppl 52:76.Google Scholar
  155. 155.
    Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801–9.PubMedCrossRefGoogle Scholar
  156. 156.
    Rothwell PM, Gibson RJ, Slattery J, et al., for the European Carotid Surgery Trialists’ Collaborative Group. Equivalence of measurements of carotid stenosis. A comparison of three methods on 1001 angiograms. Stroke 1994;25:2435–9.PubMedGoogle Scholar
  157. 157.
    Salomaa V, Stinson V, Kark JD, et al. Association of fibrinolytic parameters with early atherosclerosis. The ARIC study. Circulation 1995;91:284–90.PubMedGoogle Scholar
  158. 158.
    Salonen J, Salonen R, Korpela H, et al. Serum copper and the risk of acute myocardial infarction: a prospective population study in men in eastern finland. Am J Epidemiol 1991;134:268–76.PubMedGoogle Scholar
  159. 159.
    Salonen R, Nyyssönen K, Porkkala E, et al. Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. Circulation 1995;92:1758–64.PubMedGoogle Scholar
  160. 160.
    Salonen JT, Nyyssönen K, Salonen R, et al. Lipoprotein oxidation and progression of carotid atherosclerosis. Circulation 1997;95:840–5.PubMedGoogle Scholar
  161. 161.
    Schellong SM, Schwarz T, Kropp J, et al. Bettruhe in der Behandlung der TVT senkt die Inzidenz szintigraphisch neu auftretender Lungenembolien nicht. Vasa 1998; Suppl 52:95.Google Scholar
  162. 162.
    Schömig, A, Neumann F-J, Kastrati A, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996;334:1084–9.PubMedCrossRefGoogle Scholar
  163. 163.
    Schwartz SM, Siscovick DS, Malinow MR, et al. Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene. Circulation 1997;96:412–7.PubMedGoogle Scholar
  164. 164.
    Selhub J, Jaques PF, Bostom AG, et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995; 332:286–91.PubMedCrossRefGoogle Scholar
  165. 165.
    Simioni P, Prandoni P, Lensing AWA, et al. The risk of recurrent venous thromboembolism in patients with an Arg506(Gln mutation in the gene for factor V (factor V Leiden). N Engl J Med 1997;336:399–403.PubMedCrossRefGoogle Scholar
  166. 166.
    Speir E, Modali R, Huang ES, et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 1994;265:391–4.PubMedCrossRefGoogle Scholar
  167. 167.
    Srinivasan J, Newell DW, Sturzenegger M, et al. Transcranial Doppler in the evaluation of internal carotid artery dissection. Stroke 1996;27:1226–30.PubMedGoogle Scholar
  168. 168.
    Stroes ESG, Koomans HA, de Brujn TWA, et al. Vascular function in the forearm of hypercholesterolemic patients off and on lipid-lowering medication. Lancet 1995;346:467–71.PubMedCrossRefGoogle Scholar
  169. 169.
    Strotzer M, Fellner C, Fraunhofer S, et al. Dedicated head-neck coil in MR angiography, of the supra-aortic arteries from the aortic arch to the circle of Willis. Acta Radiol 1998;39:249–56.PubMedCrossRefGoogle Scholar
  170. 170.
    Tell GS, Polak JF, Ward BJ, et al. Relation of smoking with carotid artery wall thickness and stenosis in older adults. The Cardiovascular Health Study. Circulation 1994;90:2905–8.PubMedGoogle Scholar
  171. 171.
    The COLUMBUS Investigators. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med 1997;337:657–62.CrossRefGoogle Scholar
  172. 172.
    Theron JG, Payelle GG, Coskun O, et al. Carotid artery stenosis: treatment with protected balloon angioplasty and stent placement. Radiology 1996;201:627–36.PubMedGoogle Scholar
  173. 173.
    Ting HH, Timimi FK, Haley EA, et al. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation 1997;95:2617–22.PubMedGoogle Scholar
  174. 174.
    Wahl DG, Guillemin F, de Maistre E, et al. Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus — a meta-analysis. Lupus 1997;6:467–73.PubMedCrossRefGoogle Scholar
  175. 175.
    Wain RA, Lyon RT, Veith FJ, et al. Accuracy of duplex ultrasound in evaluating carotid artery anatomy before endarterectomy. J Vasc Surg 1998;27:235–42.PubMedCrossRefGoogle Scholar
  176. 176.
    Wankmüller H, Schwender S, Keller F. APC-Resistenz: Pathogenese, Diagnostik, Prävalenz und Bedeutung eines neuen Thromboserisikofaktors. Med Klin 1996;91:308–12.Google Scholar
  177. 177.
    Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with lowmolecular-weight heparin or unfractionated heparin. N Engl J Med 1995;332:1330–5.PubMedCrossRefGoogle Scholar
  178. 178.
    Weitz JI. Low-molecular-weight heparins. N Engl J Med 1997;337:688–98.PubMedCrossRefGoogle Scholar
  179. 179.
    Wells PS, Anderson DR, Bormanis J, et al. SimpliRED D-dimer can reduce the diagnostic tests in suspected deep-vein thrombosis. Lancet 1998;351:1405–6.PubMedCrossRefGoogle Scholar
  180. 180.
    Wells PS, Kovacs MJ, Bormanis J, et al. Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin: a comparison of patient self-injection with homecare injection. Arch Intern Med 1998;158:1809–12.PubMedCrossRefGoogle Scholar
  181. 181.
    Wholey MH, Jarmolowski CR, Eles G, et al. Endovascular stents for carotid artery occlusive disease. J Endovasc Surg 1997;4:326–38.PubMedCrossRefGoogle Scholar
  182. 182.
    Wholey MH, Wholey M, Bergeron P, et al. Current global status of carotid artery stent placement. Cathet Cardiovasc Diagn 1998;44:1–6.PubMedCrossRefGoogle Scholar
  183. 183.
    Wijman CA, Babikian VL, IC Matjucha, et al. Cerebral microembolism in patients with retinal ischemia. Stroke 1998;29:1139–43.PubMedGoogle Scholar
  184. 184.
    Wildberger JE, Vorwerk D, Kilbinger M, et al. Bedside testing (SimpliRED) in the diagnosis of deep vein thrombosis. Invest Radiol 1998;33:232–5.PubMedCrossRefGoogle Scholar
  185. 185.
    Willeit J, Kiechl S, Santer P, et al. Lipoprotein(a) and asymptomatic carotid artery disease. Evidence of a prominent role in the evolution of advanced carotid plaques: the Bruneck Study. Stroke 1995;26:1582–7.PubMedGoogle Scholar
  186. 186.
    Woo KS, Chook P, Lolin YI, et al. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans Circulation 1997;96:2542–4.PubMedGoogle Scholar
  187. 187.
    Xu Q, Willeit J, Marosi M, et al. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet 1993;341:255–9.PubMedCrossRefGoogle Scholar
  188. 188.
    Yadav JS, Roubin GS Iyer S, et al. Elective stenting of the extracranial carotid arteries. Circulation 1997;95: 376–81.PubMedGoogle Scholar
  189. 189.
    Yamashita K, Ouchi K, Shirai M, et al. Distribution of Chlamydia pneumoniac infection in the atherosclerotic carotid artery. Stroke 1998;29:773–8.PubMedGoogle Scholar
  190. 190.
    Zoli M, Merkel C, Sabba C, et al. Interobserver and inter-equipment variability of echo-Doppler sonographic evaluation of the superior mesenteric artery. J Ultrasound Med 1996;15:99–106.PubMedGoogle Scholar
  191. 191.
    Zoneraich S, Spodick DH. Bedside science reduces laboratory art. Appropriate use of physical findings to reduce reliance on sophisticated and expensive methods. Circulation 1995;91:2089–92.PubMedGoogle Scholar

Copyright information

© Urban & Vogel 1999

Authors and Affiliations

  1. 1.Medizinische Klinik II (Schwerpunkte Kardiologie und Angiologie)Ruhr-Universität BochumBochumDeutschland
  2. 2.Medizinische Klinik II (Schwerpunkte Kardiologie und Angiologie)Universität MarienhospitalHerneDeutschland

Personalised recommendations